These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1376068)

  • 1. Immunoregulatory capability of murine CLL-like CD5+ B cells.
    Phillips J; Raveché E
    Ann N Y Acad Sci; 1992 May; 651():488-90. PubMed ID: 1376068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic regulation of CD5+ B cells in autoimmune disease and in chronic lymphocytic leukemia.
    Shirai T; Okada T; Hirose S
    Ann N Y Acad Sci; 1992 May; 651():509-26. PubMed ID: 1376072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of host environment on growth of clonal CD5+B (Lyl+B) cells.
    Raveche ES; Lin TZ; Conroy J; Tjio JH; Steinberg AD; Rudolfsky UA; Phillips JA
    Autoimmunity; 1991; 10(3):217-25. PubMed ID: 1721848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feedback suppression of normal and leukemic B cell colony growth by CD5+ B cells.
    Fernandez LA; MacSween JM; Robson DA
    Ann N Y Acad Sci; 1991; 628():379-81. PubMed ID: 1712559
    [No Abstract]   [Full Text] [Related]  

  • 5. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
    Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
    Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD5 positive and negative B-CLL. Evidence supporting phenotypic heterogeneity in B-chronic lymphocytic leukemia (B-CLL).
    Faguet GB; Marti GE; Agee JF; Bertin P
    Ann N Y Acad Sci; 1992 May; 651():470-3. PubMed ID: 1376063
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of immunoglobulin from hybridomas obtained by fusing spontaneously arising CD5+ B-cell clones.
    Mahboudi F; Raveché ES
    Ann N Y Acad Sci; 1992 May; 651():369-72. PubMed ID: 1376055
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperdiploid-CD5-positive B cells in mouse.
    Raveche ES; Tjio JH
    Int J Hematol; 1991 Feb; 54(1):25-35. PubMed ID: 1954348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory aspects of clonally expanded B-1 (CD5+ B) cells.
    Raveché ES; Phillips J; Mahboudi F; Dang A; Fernandes H; Ramachandra S; Lin T; Peng B
    Int J Clin Lab Res; 1992; 22(4):220-34. PubMed ID: 1467538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines in NZB CD5+ B clones.
    Lin TZ; Svetic A; Ganea D; Rameshwar P; Gascon P; Gause W; Raveché E
    Ann N Y Acad Sci; 1992 May; 651():581-3. PubMed ID: 1376082
    [No Abstract]   [Full Text] [Related]  

  • 11. CD5 negative IGM rheumatoid factor B cells in B-chronic lymphocytic leukemia and benign mixed cryoglobulinemia.
    Martin T; Pasquali JL
    Leuk Lymphoma; 1992 May; 7(1-2):55-62. PubMed ID: 1282064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
    Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
    J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induction in CD5+(Ly1+) malignant B cells.
    Peng B; Raveche E
    Leukemia; 1993 Jun; 7(6):789-94. PubMed ID: 7684796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered CD45 expression in malignant B-1 cells.
    Dang AM; Phillips JA; Lin T; Raveche ES
    Cell Immunol; 1996 May; 169(2):196-207. PubMed ID: 8620547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages.
    Okamoto H; Nishimura H; Shinozaki A; Zhang D; Hirose S; Shirai T
    Jpn J Cancer Res; 1993 Dec; 84(12):1273-8. PubMed ID: 7507474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
    Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
    Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility complex controls clonal proliferation of CD5+ B cells in H-2-congenic New Zealand mice: a model for B cell chronic lymphocytic leukemia and autoimmune disease.
    Okada T; Takiura F; Tokushige K; Nozawa S; Kiyosawa T; Nakauchi H; Hirose S; Shirai T
    Eur J Immunol; 1991 Nov; 21(11):2743-8. PubMed ID: 1718758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic predisposition of autoimmune disease and B-cell chronic lymphocytic leukemia (B-CLL).
    Shirai T
    Tohoku J Exp Med; 1994 May; 173(1):133-40. PubMed ID: 7528945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD5+ B cells as precursors of CD5- IgG anti-DNA antibody-producing B cells in autoimmune-prone NZB/W F1 mice.
    Kanno K; Okada T; Abe M; Hirose S; Shirai T
    Ann N Y Acad Sci; 1992 May; 651():576-8. PubMed ID: 1376080
    [No Abstract]   [Full Text] [Related]  

  • 20. Surface and molecular expression of complement-receptor type 2 of neoplastic CD5+ B cells in chronic lymphocytic leukemia.
    Tooze JA; Bevan DH; Lever AM
    Ann N Y Acad Sci; 1992 May; 651():494-7. PubMed ID: 1376070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.